Nothing Special   »   [go: up one dir, main page]

Vijayan et al., 1979 - Google Patents

In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release

Vijayan et al., 1979

Document ID
15367634386762369088
Author
Vijayan E
McCann S
Publication year
Publication venue
Endocrinology

External Links

Snippet

Conscious ovariectomized rats bearing a cannula implanted in the third ventricle were injected with 2 μl 0.9% NaCl containing varying doses of substance P (SP) or neurotensin (NT), and plasma gonadotropins and PRL were measured by RIA of jugular blood samples …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Vijayan et al. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release
Vijayan et al. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats
Vijayan et al. In vivo and in vitro effects of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat
Vijayan et al. Effects of substance P and neurotensin on growth hormone and thyrotropin release in vivo and in vitro
Ottlecz et al. Regulatory role of galanin in control of hypothalamic-anterior pituitary function.
Steele et al. Effect of angiotensin II on in vivo and in vitro release of anterior pituitary hormones in the female rat
Taché et al. Brain regulation of gastric secretion: influence of neuropeptides.
Vijayan et al. Re-evaluation of the role of catecholamines in control of gonadotropin and prolactin release
VALE et al. Somatostatin
LUMPKIN et al. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat
HANEW et al. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly
Grandison et al. Location and characterization of opiate receptors regulating pituitary secretion
LUMPKIN et al. Effects of intraventricular growth hormone-releasing factor on growth hormone release: further evidence for ultrashort loop feedback
Frawley et al. Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide
KASTING et al. Pulsatile Somatostatin Release from the Median Eminence of the Unanesthetized Rat and Its Relationship to Plasnia Growth Hormone Levels
Ono et al. Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones.
Samson et al. Motilin: a novel growth hormone releasing agent
Vijayan et al. Effects of intraventricular injection of gastrin on release of LH, prolactin, TSH and GH in conscious ovariectomized rats
Arnold et al. Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid
Pappas et al. Calcitonin gene-related peptide-induced selective inhibition of gastric acid secretion in dogs
Ottlecz et al. The effects of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones
Aguila et al. Roles of somatostatin and growth hormone-releasing factor in ether stress inhibition of growth hormone release
Becker et al. Role of insulin-like growth factor l in regulating growth hormone release and feedback in the male rat
Riskind et al. Midbrain LHRH infusions enhance lordotic behavior in ovariectomized estrogen-primed rats independently of a hypothalamic responsiveness to LHRH
Abe et al. Effect of intraventricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood